Delivery Order SPE2DB24D1021-SPE2DB25FERTE
Award Date
10/30/24
Potential Completion Date
10/31/24
Potential Value
$5.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Xeljanz XR 11 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $4,829.60 delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 1, 2024, with a completion date of November 4, 2024. The contract has a firm fixed price pricing type and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Xeljanz XR 11 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical program. The $19,987.38 firm-fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 10, 2023, with a completion date of March 13, 2023. The contract is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 and running through...
This federal contract award is for the delivery of Xeljanz XR 11 mg tablets to the Defense Logistics Agency (DLA). The $2,651.84 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 10, 2023, with a performance completion date of August 11, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,164.32, is for the delivery of Xeljanz XR 11 mg tablets over a period ending on April 23, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
The federal contract award is for the delivery of Xeljanz XR 11 mg tablets to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The $3,470.13 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 28, 2024, with a completion date of October 29, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to deliver Xeljanz XR 11 mg tablets. The contract has a ceiling value of $6,252.69 and runs through August 29, 2023. This is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical, valued at up to $999,999,999. The IDC enables the DLA to...
The federal contract award is for the delivery of XELJANZ XR 11 MG TABLET UU 30S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $15,504.59, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 4, 2025 with an ultimate completion date of April 7, 2025. This is a delivery order contract with a firm fixed-price pricing type. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This federal contract award is for Xeljanz 5 mg tablets, a pharmaceutical product, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $11,003.79 and is a delivery order with a firm fixed price pricing type. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 11, 2024. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Xeljanz XR 11 mg tablets to the agency. The contract is a delivery order valued at $1,507.35, with a completion date of April 17, 2024. The contract is a firm fixed-price agreement and is not a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
This federal contract award is for the delivery of Xeljanz XR 11 mg tablets to the Defense Logistics Agency (DLA). The $16,694.36 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide...